Human Papillomavirus in Metastatic Lymph Nodes from Unknown Primary Head and Neck Squamous Cell Carcinoma

Objective. Determine human papillomavirus (HPV) incidence in unknown primary squamous cell carcinomas (SCCa) of the head and neck and assess if HPV status influenced survival. Study Design. Historical cohort study. Setting. Tertiary care center. Subjects. Patients with unknown primary SCCa despite a complete workup who underwent neck dissection or excisional biopsy and postoperative comprehensive ± chemoradiotherapy between 2002 and 2009. Methods. HPV fluorescence in situ hybridization (FISH) and p16INK4a immunohistochemistry (p16 IHC) were performed. Results were compared with survival, age, race, gender, tobacco use, alcohol use, and nodal stage. Results. Twenty-five patients met the inclusion criteria, of whom 88% were >10 pack year tobacco users. Twenty-eight percent were HPV positive defined by both p16+ and FISH+. Five-year overall survival was 66.7% in HPV-positive and 48.5% in HPV-negative patients (P = .35). Similarly, 5-year disease-free survival rates were 66.7% in HPV-positive and 48.5% in HPV-negative patients (P = .54). All 3 HPV-positive nonsmokers were survivors, but this was not significant because of the small sample size (P > .05). No other characteristics were associated with survival (P > .05). Conclusion. Twenty-eight percent of metastatic lymph nodes from occult primary tumors were HPV positive. There was no survival difference associated with HPV status. Most of the HPV-positive patients in this study were tobacco users who had similar survival to HPV-negative patients, so caution should be used in interpreting HPV status in these patients.

[1]  C. Chung,et al.  p16 Expression as a predictive biomarker of hypoxic cell-sensitizing agents in oropharyngeal cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  A. Jemal,et al.  Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.

[3]  A. Giuliano,et al.  Head and neck squamous cell cancer and the human papillomavirus: Summary of a National Cancer Institute State of the Science Meeting, November 9–10, 2008, Washington, D.C. , 2009, Head & neck.

[4]  A. Jenson,et al.  Human papillomavirus in metastatic squamous carcinoma from unknown primaries in the head and neck: a retrospective 7 year study. , 2009, Experimental and molecular pathology.

[5]  H. Christiansen,et al.  Impact of Distant Metastasis in Patients with Cervical Lymph Node Metastases from Cancer of an Unknown Primary Site , 2009, The Annals of otology, rhinology, and laryngology.

[6]  Y. Yen,et al.  Human papillomavirus infection as a prognostic factor in oropharyngeal squamous cell carcinomas treated in a prospective phase II clinical trial. , 2009, Anticancer research.

[7]  A. Psyrri,et al.  E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells. , 2009, Journal of the National Cancer Institute.

[8]  W. Westra,et al.  Basaloid Squamous Cell Carcinoma of the Head and Neck is a Mixed Variant That Can be Further Resolved by HPV Status , 2008, The American journal of surgical pathology.

[9]  S. El-Mofty,et al.  Histologic Identification of Human Papillomavirus (HPV)-Related Squamous Cell Carcinoma in Cervical Lymph Nodes: A Reliable Predictor of the Site of an Occult Head and Neck Primary Carcinoma , 2008, Head and neck pathology.

[10]  S. Goldie,et al.  The economic burden of noncervical human papillomavirus disease in the United States. , 2008, American journal of obstetrics and gynecology.

[11]  A. Cmelak,et al.  Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. , 2008, Journal of the National Cancer Institute.

[12]  E. Robertson,et al.  Increased viral load correlates with improved survival in HPV-16-associated tonsil carcinoma patients , 2008, Acta oto-laryngologica.

[13]  Maureen M. O’Brien,et al.  Rising Incidence of Oropharyngeal Cancer and the Role of Oncogenic Human Papilloma Virus , 2007, The Laryngoscope.

[14]  Carole Fakhry,et al.  Case-control study of human papillomavirus and oropharyngeal cancer. , 2007, The New England journal of medicine.

[15]  P. Boscolo-Rizzo,et al.  Carcinoma Metastatic to Cervical Lymph Nodes From an Occult Primary Tumor: The Outcome After Combined-Modality Therapy , 2007, Annals of Surgical Oncology.

[16]  D. Parkin,et al.  The global health burden of infection‐associated cancers in the year 2002 , 2006, International journal of cancer.

[17]  D. Rimm,et al.  Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  T. Rezanko,et al.  Human papillomavirus genome detection by in situ hybridization in fine‐needle aspirates of metastatic lesions from head and neck squamous cell carcinomas , 2005, Cancer.

[19]  H. Christiansen,et al.  Neck Lymph Node Metastases from an Unknown Primary Tumor , 2005, Strahlentherapie und Onkologie.

[20]  T. Görögh,et al.  Human papillomaviruses in lymph node neck metastases of head and neck cancers , 2005, Acta oto-laryngologica.

[21]  M. Gillison,et al.  Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. , 2004, Seminars in oncology.

[22]  K. Shah,et al.  Detection of human papillomavirus in cervical lymph nodes: a highly effective strategy for localizing site of tumor origin. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[23]  S. Franceschi,et al.  Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. , 2003, Journal of the National Cancer Institute.

[24]  M. Schiffman,et al.  Human Papillomavirus Epidemiology and Public Health , 2022 .

[25]  R. Engers,et al.  Diagnostic strategies in cervical carcinoma of an unknown primary (CUP) , 2002, European Archives of Oto-Rhino-Laryngology.

[26]  I. Haas,et al.  Comments on the publication: Haas I. et al. (2001) The dilemma of follow-up in head and neck cancer patients. Eur Arch Otorhinolaryngol 258: 177-183 , 2002, European Archives of Oto-Rhino-Laryngology.

[27]  A. Garden,et al.  Postoperative radiation for squamous cell carcinoma metastatic to cervical lymph nodes from an unknown primary site: Outcomes and patterns of failure , 1998, Head & neck.

[28]  R. Kurman,et al.  Generation of type-specific probes for the detection of single-copy human papillomavirus by a novel in situ hybridization method. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[29]  J. Stockman.  Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer , 2012 .

[30]  A. Giuliano,et al.  HEAD AND NECK SQUAMOUS CELL CANCER AND THE HUMAN PAPILLOMAVIRUS: SUMMARY OF A NATIONAL CANCER INSTITUTE STATE OF THE SCIENCE MEETING, , 2009 .

[31]  F. Bosch,et al.  Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. , 1998, Cancer research.

[32]  Jane A. Langdale,et al.  In situ Hybridization , 1994 .